We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Calf Muscle Atrophy After Achilles Tendon Rupture. A Clinical-Radiological-Biomechanical Multicenter Study.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01778816
Recruitment Status : Completed
First Posted : January 29, 2013
Last Update Posted : January 29, 2013
Hospital Fribourg, Switzerland
Hospital Liestal, Switzerland
Information provided by (Responsible Party):
Claudio Rosso, University Hospital, Basel, Switzerland

Brief Summary:

Multicenter Achilles tendon study Switzerland. Comparing three mainstream treatment types: open, percutaneous and conservative (non-operative) treatments.

Comparing force torque measurements, muscle volume and clinical scores.

Condition or disease
Achilles Tendon Ruptures

Study Type : Observational
Actual Enrollment : 52 participants
Observational Model: Cohort
Time Perspective: Retrospective
Study Start Date : January 2009
Primary Completion Date : July 2009
Study Completion Date : December 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tears
U.S. FDA Resources

Primary Outcome Measures :
  1. Muscle Volume [ Time Frame: at least 3 years after injury ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   20 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
  • Age 20-65 years
  • BMI < 40
  • no injury to leg
  • no injury on contralateral leg

Inclusion Criteria:

  • 20-65 years of age,
  • a healthy, contralateral leg
  • physiological, clinically determined alignment of the knee, foot and ankle
  • no trauma to the healthy leg
  • no neuromuscular impairments including muscle dystrophies
  • no other posttraumatic injuries or osteoarthritis of the knee, foot or ankle of the affected leg.

Exclusion Criteria:

  • re-rupture or reoperation of the Achilles tendon
  • surgical site infection
  • neuromuscular diseases including muscle dystrophies
  • ankle valgus of more than 15° or ankle varus of more than 5°
  • other known pathologies of the non-affected leg
  • general MRI exclusion criteria (e.g. pacemaker, other metal not qualifying for an MRI, tattoos and claustrophobia)
  • body mass index (BMI) of > 40 kg/m2

Responsible Party: Claudio Rosso, Claudio Rosso MD MSc, University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT01778816     History of Changes
Other Study ID Numbers: RossoAchilles
First Posted: January 29, 2013    Key Record Dates
Last Update Posted: January 29, 2013
Last Verified: January 2013

Keywords provided by Claudio Rosso, University Hospital, Basel, Switzerland:
Achilles tendon, muscle volume, Achilles tendon length, force, ATRS, Hannover, AOFAS

Additional relevant MeSH terms:
Wounds and Injuries